Pharmaceutical and professional services industries outrank retail and telecom sectors in employee well-being efforts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
UBS Reiterates Buy on Cigna Corp. (CI) Following 3Q
November 9, 2015 10:54 AM ESTUBS reiterated a Buy rating on CIGNA (NYSE: CI), and cut the price target to $172.00 (from $175.00), following the company's 3Q earnings report. For 2016, Cigna expects to maintain its public exchange footprint. Cigna participated in limited markets in eight states for 2015, and the company is... More
Positive Operating Execution and SG&A Improvement Drives EPS Beat For Cigna Corp. (CI); Wedbush Remains Neutral
November 9, 2015 8:01 AM ESTWedbush maintained a Neutral rating on CIGNA (NYSE: CI), and cut the price target to $175.00 (from $186.00), following the company's 3Q15 earnings report. Adjusted EPS of $2.28, vs. consensus of $2.20, was driven by positive operating execution with better than expected SG&A improvement. 2015 EPS guidance was raised to $8.40-8.60 from $8.30-8.60 vs. consensus of $8.62.
Analyst Sarah James commented, "Adjusted EPS of $2.28 vs.... More
